- Book
- April 2019
- 512 Pages
- Book
- April 2019
- 280 Pages
- Book
- February 2019
- 456 Pages
- Book
- March 2012
- 352 Pages
- Book
- March 2025
- 352 Pages
- Book
- November 2024
- 448 Pages
- Book
- October 2022
- 656 Pages
- Book
- August 2022
- 960 Pages
- Book
- August 2022
- 416 Pages
- Book
- April 2022
- 592 Pages
- Book
- June 2021
- 480 Pages
- Book
- May 2021
- 672 Pages
- Book
- December 2020
- 304 Pages
- Book
- January 2020
- 480 Pages
- Book
- May 2018
- 272 Pages

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more